aTyr Pharma to Present at Upcoming Investor Conferences

Rhea-AI Summary

aTyr Pharma (NASDAQ: ATYR), a clinical stage biotech company, has announced its participation in three upcoming investor conferences in May-June 2025. CEO Sanjay S. Shukla will present at the RBC Capital Markets Global Healthcare Conference (May 21), Piper Sandler Virtual Lung Symposium (May 27), and Jefferies Global Healthcare Conference (June 5). The presentations at RBC and Jefferies will be available via webcast on the company's website for 90 days, with one-on-one investor meetings available at these events. aTyr focuses on developing first-in-class medicines from tRNA synthetase biology, with their lead candidate efzofitimod targeting interstitial lung disease treatment.

News Market Reaction

+1.45%

1 alert

+1.45% News Effect

On the day this news was published, ATYR gained 1.45%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present at several upcoming investor conferences scheduled to take place in May and June 2025.

Details of the conferences appear below:

Conference: RBC Capital Markets Global Healthcare Conference
Date: Wednesday, May 21, 2025
Time: 11:00am EDT
Location: New York, NY
Format: Fireside Chat

Conference: Piper Sandler 3^rd Annual Virtual Lung Symposium with ATS Takeaways
Date: Tuesday, May 27, 2025
Time: 2:00pm EDT
Location: Virtual
Format: Fireside Chat

Conference: Jefferies Global Healthcare Conference
Date: Thursday, June 5, 2025
Time: 2:00pm EDT
Location: New York, NY
Format: Fireside Chat

In addition to the presentations, company management will be available to participate in one-on-one meetings with investors who are registered attendees of the RBC and Jefferies conferences. A webcast of the RBC and Jefferies events will be available on the Investor’s section of the company’s website at www.atyrpharma.com. Following the events, a replay of the RBC and Jefferies presentations will be available on the aTyr website for at least 90 days. For more information, contact investorrelations@atyrpharma.com.

About aTyr

aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases are ancient, essential proteins that have evolved novel domains that regulate diverse pathways extracellularly in humans. aTyr’s discovery platform is focused on unlocking hidden therapeutic intervention points by uncovering signaling pathways driven by its proprietary library of domains derived from all 20 tRNA synthetases. aTyr’s lead therapeutic candidate is efzofitimod, a first-in-class biologic immunomodulator in clinical development for the treatment of interstitial lung disease, a group of immune-mediated disorders that can cause inflammation and progressive fibrosis, or scarring, of the lungs. For more information, please visit www.atyrpharma.com.

Contact:
Ashlee Dunston
Sr. Director, Investor Relations and Public Affairs
adunston@atyrpharma.com

FAQ

What investor conferences will ATYR present at in May-June 2025?

ATYR will present at three conferences: RBC Capital Markets Global Healthcare Conference (May 21), Piper Sandler Virtual Lung Symposium (May 27), and Jefferies Global Healthcare Conference (June 5).

Who will be presenting at the conferences for ATYR?

Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer of aTyr Pharma, will be presenting at the conferences.

What is ATYR's lead therapeutic candidate?

aTyr's lead therapeutic candidate is efzofitimod, a first-in-class biologic immunomodulator for treating interstitial lung disease.

How can investors access ATYR's conference presentations?

Webcasts of the RBC and Jefferies events will be available on aTyr's website (www.atyrpharma.com) in the Investor's section, with replays available for 90 days after the events.